CN1314429C - 一种治疗心律失常的中药物及其制备方法 - Google Patents
一种治疗心律失常的中药物及其制备方法 Download PDFInfo
- Publication number
- CN1314429C CN1314429C CNB031343503A CN03134350A CN1314429C CN 1314429 C CN1314429 C CN 1314429C CN B031343503 A CNB031343503 A CN B031343503A CN 03134350 A CN03134350 A CN 03134350A CN 1314429 C CN1314429 C CN 1314429C
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- powder
- chinese medicine
- relative density
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 206010003119 arrhythmia Diseases 0.000 title abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 238000002481 ethanol extraction Methods 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241000208340 Araliaceae Species 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 239000000341 volatile oil Substances 0.000 claims description 9
- 241000237636 Pheretima Species 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000006793 arrhythmia Effects 0.000 abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 241001448421 Ophiopogon jaburan Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000219780 Pueraria Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000002861 ventricular Effects 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000021760 high fever Diseases 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 206010042434 Sudden death Diseases 0.000 description 2
- 208000001871 Tachycardia Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000008862 fructus schizandrae, radix ginseng, radix ophiopogonis drug combination Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000006794 tachycardia Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 241000208011 Digitalis Species 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- NZLBHDRPUJLHCE-UHFFFAOYSA-N aprindine Chemical compound C1C2=CC=CC=C2CC1N(CCCN(CC)CC)C1=CC=CC=C1 NZLBHDRPUJLHCE-UHFFFAOYSA-N 0.000 description 1
- 229960004957 aprindine Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000036515 potency Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- -1 urine Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031343503A CN1314429C (zh) | 2003-07-03 | 2003-07-03 | 一种治疗心律失常的中药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031343503A CN1314429C (zh) | 2003-07-03 | 2003-07-03 | 一种治疗心律失常的中药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1565540A CN1565540A (zh) | 2005-01-19 |
CN1314429C true CN1314429C (zh) | 2007-05-09 |
Family
ID=34470172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031343503A Expired - Lifetime CN1314429C (zh) | 2003-07-03 | 2003-07-03 | 一种治疗心律失常的中药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1314429C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100348232C (zh) * | 2005-11-09 | 2007-11-14 | 中国科学院长春应用化学研究所 | 一种治疗心律失常的中药组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1334121A (zh) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | 一种通心络药物组合物及应用 |
CN1362255A (zh) * | 2001-12-25 | 2002-08-07 | 哈药集团世一堂制药厂 | 一种治疗冠心病的中药及其制法 |
-
2003
- 2003-07-03 CN CNB031343503A patent/CN1314429C/zh not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1334121A (zh) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | 一种通心络药物组合物及应用 |
CN1362255A (zh) * | 2001-12-25 | 2002-08-07 | 哈药集团世一堂制药厂 | 一种治疗冠心病的中药及其制法 |
Also Published As
Publication number | Publication date |
---|---|
CN1565540A (zh) | 2005-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007006203A1 (fr) | Préparation de capsule pour le traitement de l’hypertension et de maladies coronariennes et procédé de préparation de celle-ci | |
US20230321125A1 (en) | Compositions of ginsenoside rg3 and ginsenoside rg5 and their pharmaceutical uses including anti-tumor effects | |
CN102579610B (zh) | 一种治疗脑出血的中药组合物及其制备方法 | |
CN112057501A (zh) | 用于治疗肌肉萎缩与肌无力的中药组合物、中药药膏及外用热敷膏药贴 | |
CN103989970A (zh) | 一种中药组合物及其在制备治疗高血压药物中的用途 | |
CN101020016B (zh) | 治疗骨折和伤筋的药物及其制备方法 | |
CN1173726C (zh) | 一种治疗恶性肿瘤病的药物及其制备方法 | |
CN102178798A (zh) | 一种用于降低血脂、防治心脑血管疾病的制剂 | |
CN1314429C (zh) | 一种治疗心律失常的中药物及其制备方法 | |
CN1137706C (zh) | 一种治疗高脂血症的药物 | |
CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
CN106581109A (zh) | 一种用于治疗脑血栓的药物组合物 | |
CN103520684B (zh) | 一种降血糖的中药复合物 | |
CN101549140B (zh) | 治疗艾滋病的中药组合物及其制备方法 | |
CN101816708B (zh) | 治疗风湿病的中药组合物及其制备方法 | |
CN101732657A (zh) | 一种药物组合物 | |
CN110215474B (zh) | 一种活血化瘀中药组合物及其应用 | |
CN113041254B (zh) | 一种金骨莲中药组合物及其制备方法 | |
CN114533835B (zh) | 一种具有芳香、祛风利湿功效的药物及其制备方法 | |
CN102526211A (zh) | 一种治疗便秘口服药物的组方及制备工艺 | |
CN101214302A (zh) | 一组治疗抑郁症伴生功能性消化不良的药物组合物及制法 | |
CN100522197C (zh) | 治疗高脂血症的中药制剂及其制备方法 | |
CN107007697A (zh) | 一种治疗***或***炎的中药组合物及其制剂 | |
CN105031364A (zh) | 一种防治风火牙痛的制剂及制备方法 | |
CN1209139C (zh) | 一种主治血管性痴呆的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HU'NAN QIU ZEYOU PATENT STRATEGIC PLANNING CO., LT Free format text: FORMER OWNER: QIU ZEYOU Effective date: 20101028 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 410011 28/F, SHUNTIANCHENG, NO.59, SECTION 2 OF FURONG MIDDLE ROAD, CHANGSHA CITY, HU'NAN PROVINCE TO: 410205 JUXING INDUSTRY BASE, NO.8, LUJING ROAD, CHANGSHA HIGH-TECH. DEVELOPMENT ZONE, YUELU DISTRICT, CHANGSHA CITY, HU'NAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101105 Address after: 712000 Xianyang City, Shaanxi province Baoquan Road No. 1 Building 6 floor Carey Patentee after: SHAANXI JIANMIN PHARMACEUTICAL Co.,Ltd. Address before: Xianyang City, Shaanxi Province, 712000 West Road No. 6 Patentee before: Guo Junjing |
|
CX01 | Expiry of patent term |
Granted publication date: 20070509 |
|
CX01 | Expiry of patent term | ||
DD01 | Delivery of document by public notice |
Addressee: Qiao Donghu Document name: Notice of Termination of Patent Rights |
|
DD01 | Delivery of document by public notice |